BRIEF published on 11/12/2024 at 13:05, 1 year ago Yunu nomme Patrick McNamara pour accélérer sa croissance Yunu Développement Des Affaires Sciences De La Vie Patrick McNamara Imagerie D'essais Cliniques
BRIEF published on 11/12/2024 at 13:05, 1 year ago Yunu Appoints Patrick McNamara to Accelerate Growth Business Development Life Sciences Yunu Clinical Trial Imaging Patrick McNamara
PRESS RELEASE published on 11/12/2024 at 13:00, 1 year ago Yunu Welcomes Veteran Life Sciences Commercial Leader Patrick McNamara Yunu appoints Patrick McNamara as Senior VP of Business Development to drive growth initiatives in life sciences sector with expertise in clinical trial imaging workflow and data management solutions Business Development Life Sciences Yunu Clinical Trial Imaging Patrick McNamara
BRIEF published on 09/12/2024 at 13:05, 1 year 2 months ago Yunu étend l'utilisation gratuite de la plateforme du centre de cancérologie pour tous les essais cliniques du groupe d'oncologie pédiatrique Yunu Recherche Clinique Technologie D'imagerie Essais Cliniques Du COG Cancer Pédiatrique
BRIEF published on 09/12/2024 at 13:05, 1 year 2 months ago Yunu Extends Free Cancer Center Use of Platform for All Children's Oncology Group Clinical Trials Clinical Research Imaging Technology Yunu COG Clinical Trials Pediatric Cancer
PRESS RELEASE published on 09/12/2024 at 13:00, 1 year 2 months ago Yunu Extends Free Cancer Center Use of Platform for All Children’s Oncology Group Clinical Trials Yunu extends free platform use for Children's Oncology Group (COG) trials nationwide, providing world-class imaging capabilities and transforming pediatric cancer care Clinical Trials Yunu Imaging Workflow Pediatric Cancer Children's Oncology Group
BRIEF published on 07/23/2024 at 13:05, 1 year 4 months ago Taux d'erreur d'imagerie de 50 % dans les essais cliniques discutés par des panélistes d'experts de 5 centres de cancérologie désignés par le NCI Essais Cliniques Recherche Médicale Oncologie Erreurs D'imagerie Plateforme Yunu
BRIEF published on 07/23/2024 at 13:05, 1 year 4 months ago 50% Imaging Error Rate in Clinical Trials Discussed by Expert Panelists from 5 NCI-Designated Cancer Centers Clinical Trials Oncology Medical Research Imaging Errors Yunu Platform
PRESS RELEASE published on 07/23/2024 at 13:00, 1 year 4 months ago 50% Imaging Error Rate in Clinical Trials Discussed by Expert Panelists from 5 NCI-Designated Cancer Centers Panel at AACI-CRI symposium highlights concerning imaging accuracy crisis in clinical trials. Yunu's platform addresses issues, leading to significant workflow efficiencies Clinical Trials Yunu Imaging Accuracy Workflow Efficiencies AACI-CRI Symposium
BRIEF published on 05/08/2024 at 13:05, 1 year 6 months ago Yunu Introduces Advanced Imaging Workflow for Investigator-Initiated Trials Data Management Yunu Clinical Trial Imaging Cloud-based Platform Investigator-initiated Trials
Published on 12/05/2025 at 02:35, 4 hours 7 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 42 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 37 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 42 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 12 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 51 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 17 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 27 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 32 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:14, 12 hours 28 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 12 hours 42 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 12 hours 42 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 57 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 12 hours 57 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
